ARCHIVES

NCI advisors seek comment on clinical trials system, until Jan. 15.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 2 Issue 3, Summer 1988

June 13, 1988

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005

NCCS Networker Volume 1 Issue 2, Summer 1987

June 13, 1987

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001